Good news, Colleague - your sale + an extra 25% off is here

Preview text: Good news - your sale + an extra 25% off is here 96 Save more when you use the code…

Saturday, Aug 8, 2026 at 8:57 AM EasternHubSpot

PESIGood news, Colleague - your sale + an extra 25% off is here

Image not available

No image available for this email.

Subject: Good news, Colleague - your sale + an extra 25% off is here
Preview text: Good news - your sale + an extra 25% off is here 96 Save more when you use the code…
From: info@pesieducation.co.uk
Brand: PESI
ESP: HubSpot
Sent: Sat Aug 8, 2026, 8:57 AM ET
Sent to: United Kingdom (pesi.co.uk)
Size: 88 KB
Images: 9
Links: 20, 9 of them buttons
Subject length: 59 characters

Against PESI's usual

Sent in the 8 AM hour, which holds 10% of its emails; 12% arrive in the 10 AM hour. The subject is 59 characters; its average is 51.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: PESI UK <[email protected]>
Reply-To: [email protected]
Subject: Good news, Colleague - your sale + an extra 25% off is here
Date: Sat, 8 Aug 2026 07:57:19 -0500
Message-ID domain: 6951996m.pesieducation.com
Return-Path domain: 6951996m.pesieducation.com
DKIM signature: d=6951996m.pesieducation.com s=hs2; d=pesieducation.co.uk s=hs2
List-Unsubscribe: Present, one-click
Feedback-ID sender: HubSpot

from bid459x.….pesieducation.com [158.247.16.115] by our receiving server with ESMTPS

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

	Aug 9, 2026 3:03 PM	This is more than just a trendy buzzword. It’s a practical approach that leads to tangible results.
	Aug 9, 2026 12:03 PM	Colleague, this exclusive opportunity might be just what you need
	Aug 9, 2026 9:08 AM	£20 CPD for Friend
	Aug 8, 2026 8:57 AM	Good news, Colleague - your sale + an extra 25% off is here (this email)
	Aug 7, 2026 3:03 PM	When it’s not easy to tell the difference... you need an approach that covers both
	Aug 7, 2026 11:59 AM	The NHS-approved modality that doesn't just focus on symptoms
	Aug 7, 2026 9:00 AM	You'll want to open this email, Colleague